Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world

PURPOSE: This study aimed to assess the efficacy and safety of a triple therapy that comprises transarterial chemoembolization (TACE), antiangiogenic-targeted therapy, and programmed death-1 (PD-1) inhibitors in a real-world cohort of patients with unresectable hepatocellular carcinoma (HCC) with po...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jin-Kai, Liu, Zong-Han, Fu, Zhi-Gang, Chai, Zong-Tao, Sun, Ju-Xian, Wang, Kang, Cheng, Yu-Qiang, Zhu, Hong-Fei, Xiang, Yan-Jun, Zhou, Li-Ping, Shi, Jie, Guo, Wei-Xing, Zhai, Jian, Cheng, Shu-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732723/
https://www.ncbi.nlm.nih.gov/pubmed/36505818
http://dx.doi.org/10.3389/fonc.2022.954203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732723/
https://www.ncbi.nlm.nih.gov/pubmed/36505818
http://dx.doi.org/10.3389/fonc.2022.954203

Ejemplares similares